Skip to search.
 TSX Up 0.44% TSX Ventures Up 0.66%

More On BLU.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

BELLUS Health, Inc. (BLU.TO)

-Toronto
1.09 0.00(0.00%) Jun 29, 3:56PM EDT
Add to Portfolio
Prev Close:1.09
Open:1.09
Bid:1.10
Ask:1.15
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:1.09 - 1.15
52wk Range:0.95 - 1.80
Volume:4,535
Avg Vol (3m):9,300
Market Cap:51.69M
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BELLUS Health Inc., together with its subsidiaries, focuses on the research and development of pharmaceutical drug candidates. The company’s lead program is KIACTA, which is in Phase III clinical trial for the treatment of AA amyloidosis. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback